Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding.

It has been suggested that fibrinogen (fg) or its physiological derivatives influence the motility and growth of endothelial cells (ECs), but direct support for this concept is still lacking. In the present study, the capacity of fg to interact with ECs and induce the migration of ECs was examined. The capacity of fg to induce EC migration was studied by means of a modification of the Boyden chamber technique. fg in the lower compartment of the chamber caused a time- and concentration-dependent migration of ECs across filters. fg present in equal concentrations above and below the filter increased EC migration, but the maximal effect invariably occurred in the presence of a gradient between the lower and the upper compartments. Trypsin or plasmin digestion of fg and preincubation of fg with Fab fragments from specific antibody completely abolished fg-induced EC migration. Dialysis of fg to eliminate small peptides that might contaminate the preparation did not modify fg-induced migration. Plasma obtained from healthy donors induced EC migration, but plasma from an afibrinogenemic patient was completely ineffective. The addition of purified fg to afibrinogenemic plasma restored plasma-induced EC migration. Plasmin degradation fragments D and E, of 100,000 and 50,000 mol wt, respectively, did not induce EC migration. However, fragment E caused dose-related inhibition of fg-induced EC migration Direct interaction of highly purified radioiodinated human fg with cultured human and bovine Ecs was observed. The binding was time dependent and plateaued at 10 min. Nonlabeled fg in a large molar excess inhibited the interaction, but unrelated proteins, including fibronectin, ovalbumin, and myoglobin, did not. Monospecific Fab fragments directed to fg inhibited binding by 38% at a 50 to 1 molar ratio whereas nonimmune Fab caused only 2% inhibition at a similar concentration. The binding of 125I-fg with ECs was saturable, and an apparent dissociation constant of 0.23 x 10(-6) M was estimated from binding isotherms. After 30 min of incubation the interaction between 125I-fg and the cells was completely reversible and displaceable by a large molar excess of unlabeled fg. Autoradiography of the display of EC-bound 125I on polyacrylamide gel showed the constitutive B beta- and gamma-chains of the fg molecule, with a partial loss of the A alpha-chain. Purified fragment E and E were tested for their capacity to inhibit fg binding. At a 1 to 400 125I-fg-to-fragment molar ratio, fragment E, which also inhibited migration, competed for binding by 44%, but fragment D was completely ineffective. These data show that fg may specifically associate with ECs and induce migration of these cells; it also appears that the structural requirement of this activity is located in the N-terminal part of the molecule.

[1]  E. Dejana,et al.  Specific binding of human fibrinogen to cultured human fibroblasts. Evidence for the involvement of the E domain. , 1984, European Journal of Biochemistry.

[2]  A. Mantovani,et al.  Regulation of the macrophage content of neoplasms by chemoattractants. , 1983, Science.

[3]  M Rocchetti,et al.  NL-FIT: a microcomputer program for non-linear fitting. , 1983, Computer programs in biomedicine.

[4]  P. Allavena,et al.  Defective natural killer activity within human ovarian tumors: low numbers of morphologically defined effectors present in situ. , 1983, Journal of the National Cancer Institute.

[5]  S. Witte The endoendothelial lining as studied by a fluorescent labeling technique in situ. , 1983, Thrombosis research. Supplement.

[6]  L. Larizza,et al.  Activation of cyclophosphamide by freeze-dried microsomes as an in vitro test of cytogenetic damage. , 1982, Mutation research.

[7]  N. Ardaillou,et al.  The binding of fibrinogen to its platelet receptor. , 1982, The Journal of biological chemistry.

[8]  W. Cruikshank,et al.  Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. , 1982, Journal of immunology.

[9]  E. Plow,et al.  The interaction of fibrinogen with human platelets in a plasma milieu. , 1982, Blood.

[10]  E. Dejana,et al.  Evidence that Vascular Endothelial Cells Can Induce the Retraction of Fibrin Clots , 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  A. Budzynski,et al.  Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. , 1981, The Journal of biological chemistry.

[12]  Patricia A. D'Amore,et al.  Adult tissues contain chemo-attractants for vascular endothelial cells , 1980, Nature.

[13]  M. Hollenberg,et al.  Epidermal growth factor-urogastrone: biological activity and receptor binding of derivatives. , 1980, Molecular pharmacology.

[14]  J. Lavergne,et al.  Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease. , 1980, The Journal of laboratory and clinical medicine.

[15]  M. Donati,et al.  MALIGNANCY AND HAEMOSTASIS , 1980, British journal of haematology.

[16]  J. Lanigan,et al.  Cell surface fibrinogen-fibrin receptors on cultured human fibroblasts. Association with fibronectin (cold insoluble globulin, LETS protein) and loss in SV40 transformed cells. , 1979, Laboratory investigation; a journal of technical methods and pathology.

[17]  T. Edgington,et al.  Human Platelets Possess an Inducible and Saturable Receptor Specific for Fibrinogen , 1979, Thrombosis and Haemostasis.

[18]  E. Manseau,et al.  Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. , 1979, Journal of the National Cancer Institute.

[19]  J. Folkman,et al.  The effect of fibrin on cultured vascular endothelial cells. , 1979, Tissue & cell.

[20]  E. Engvall,et al.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen , 1977, International journal of cancer.

[21]  L. Sherman,et al.  Specific binding of soluble fibrin to macrophages , 1977, The Journal of experimental medicine.

[22]  H. Dvorak,et al.  Fibrinogen/fibrin on the surface of macrophages: detection, distribution, binding requirements, and possible role in macrophage adherence phenomena , 1975, The Journal of experimental medicine.

[23]  Sally H. Zigmond,et al.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. , 1973 .

[24]  P. Gaffney Heterogeneity of human fibrinogen. , 1971, Nature: New biology.

[25]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.